Hirashima Y - Search Results

1

Anti-phospholipid antibodies and cerebral vasospasm following subarachnoid haemorrhage.

Hirashima Y, Kurimoto M, Tsukamoto E, Endo S, Takaku A. Hirashima Y, et al. Acta Neurochir (Wien). 1995;135(3-4):191-7. doi: 10.1007/BF02187767. Acta Neurochir (Wien). 1995. PMID: 8748813

2

Sequential changes in the platelet count in patients with symptomatic vasospasm after subarachnoid hemorrhage.

Hirashima Y, Hayashi N, Endo S, Takaku A. Hirashima Y, et al. Neurol Med Chir (Tokyo). 1993 Apr;33(4):220-4. doi: 10.2176/nmc.33.220. Neurol Med Chir (Tokyo). 1993. PMID: 7685852 Free article.

3

The use of computed tomography in the prediction of delayed cerebral infarction following acute aneurysm surgery for subarachnoid haemorrhage.

Hirashima Y, Kurimoto M, Takaba M, Endo S, Takaku A. Hirashima Y, et al. Acta Neurochir (Wien). 1995;132(1-3):9-13. doi: 10.1007/BF01404841. Acta Neurochir (Wien). 1995. PMID: 7754865

4

Platelet-activating factor and antiphospholipid antibodies in subarachnoid haemorrhage.

Hirashima Y, Endo S, Kurimoto M, Tsukamoto E, Takaku A. Hirashima Y, et al. Acta Neurochir (Wien). 1994;128(1-4):144-9. doi: 10.1007/BF01400665. Acta Neurochir (Wien). 1994. PMID: 7847132

5

An experimental model of symptomatic vasospasm induced by oxyhemoglobin in rabbits.

Otsuji T, Endo S, Hirashima Y, Nishijima M, Takaku A. Otsuji T, et al. Among authors: hirashima y. Stroke. 1994 Mar;25(3):657-62. doi: 10.1161/01.str.25.3.657. Stroke. 1994. PMID: 8128522

6

Platelet-activating factor (PAF) concentration and PAF acetylhydrolase activity in cerebrospinal fluid of patients with subarachnoid hemorrhage.

Hirashima Y, Endo S, Ohmori T, Kato R, Takaku A. Hirashima Y, et al. J Neurosurg. 1994 Jan;80(1):31-6. doi: 10.3171/jns.1994.80.1.0031. J Neurosurg. 1994. PMID: 8271019

7

Platelet-activating factor and cerebral vasospasm following subarachnoid hemorrhage.

Hirashima Y, Endo S, Otsuji T, Karasawa K, Nojima S, Takaku A. Hirashima Y, et al. J Neurosurg. 1993 Apr;78(4):592-7. doi: 10.3171/jns.1993.78.4.0592. J Neurosurg. 1993. PMID: 8450333

8

Prevention of cerebrovasospasm following subarachnoid hemorrhage in rabbits by the platelet-activating factor antagonist, E5880.

Hirashima Y, Endo S, Kato R, Takaku A. Hirashima Y, et al. J Neurosurg. 1996 May;84(5):826-30. doi: 10.3171/jns.1996.84.5.0826. J Neurosurg. 1996. PMID: 8622157

9

Platelet-activating factor (PAF) and the formation of chronic subdural haematoma. Measurement of plasma PAF levels and anti-PAF immunoglobulin titers.

Hirashima Y, Endo S, Hayashi N, Karasawa K, Nojima S, Takaku A. Hirashima Y, et al. Acta Neurochir (Wien). 1995;137(1-2):15-8. doi: 10.1007/BF02188773. Acta Neurochir (Wien). 1995. PMID: 8748861

10

Plasma platelet-derived growth factor-B chain is elevated in patients with extensively large brain tumour.

Kurimoto M, Nishijima M, Hirashima Y, Endo S, Takaku A. Kurimoto M, et al. Among authors: hirashima y. Acta Neurochir (Wien). 1995;137(3-4):182-7. doi: 10.1007/BF02187191. Acta Neurochir (Wien). 1995. PMID: 8789659

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

321 results

Search Page

Filters